Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 172INDUSTRY 10OTHER_GOV 9NETWORK 3UNKNOWN 2NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Other neoplasm 1

Conditions

Locally Advanced Malignant Neoplasm 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Paclitaxel 20Capecitabine 18S 1 (combination) 17Cisplatin 15Oxaliplatin 11apatinib 8Radiotherapy, Intensity-Modulated 8Epirubicin 8Docetaxel 8Carboplatin 8Radiotherapy 7Irinotecan 7titanium silicide 6sintilimab 6pyrotinib 6nimotuzumab 6anlotinib 6Albumin-Bound Paclitaxel 6130-nm albumin-bound paclitaxel 6nedaplatin 5camrelizumab 5Temozolomide 5Etoposide 5Drug Therapy 5Bevacizumab 5nabiximols 4Vinorelbine 4Trastuzumab 4Radiation Dose Hypofractionation 4Pemetrexed 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
UNKNOWN × Interventional × Chemoradiotherapy × Clear all
NCT01871363 2013-06-06

Phase II Study of Preoperative IMRT Combined With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer

ChineseAMS

Phase 2 Unknown
35 enrolled
Other neoplasm

Locally Advanced Malignant Neoplasm

NCT01494558 2011-12-19

Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer

ChineseAMS

Phase 2/3 Completed
200 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡